<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>American Century One Choice Blend+ 2045 Portfolio R6 Class — News on 6ix</title>
    <link>https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class</link>
    <description>Latest news and press releases for American Century One Choice Blend+ 2045 Portfolio R6 Class on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/american-century-one-choice-blend-2045-portfolio-r6-class" rel="self" type="application/rss+xml" />
    <item>
      <title>The Manitowoc Company Schedules First-Quarter 2026 Earnings Announcement and Conference Call</title>
      <link>https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-11</link>
      <guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-11</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>MILWAUKEE, Wis.--(BUSINESS WIRE)-- The Manitowoc Company, Inc. (NYSE: MTW) announced today that it will release its first-quarter 2026 results on Tuesday,</description>
    </item>
    <item>
      <title>Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease</title>
      <link>https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/belite-bio-initiates-rolling-submission-of-new-drug-application-to-the-us-food-and-drug-administration-for-tinlarebant-for-the-treatment-of-stargardt-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/belite-bio-initiates-rolling-submission-of-new-drug-application-to-the-us-food-and-drug-administration-for-tinlarebant-for-the-treatment-of-stargardt-disease</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>Belite expects to complete the new drug application submission in the second quarter of 2026Rolling submission initiated under Breakthrough Therapy</description>
    </item>
    <item>
      <title>F&amp;M Bank Announces Appointment of Shalini Singhal to Chief Information and Technology Officer</title>
      <link>https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/fandm-bank-announces-appointment-of-shalini-singhal-to-chief-information-and-technology-officer-31</link>
      <guid isPermaLink="true">https://6ix.com/company/american-century-one-choice-blend-2045-portfolio-r6-class/news/fandm-bank-announces-appointment-of-shalini-singhal-to-chief-information-and-technology-officer-31</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>ARCHBOLD, Ohio, April 21, 2026 (GLOBE NEWSWIRE) -- F&amp;M Bank (“F&amp;M”), an Archbold, Ohio-based bank owned by Farmers &amp; Merchants Bancorp, Inc. (Nasdaq: FMAO),</description>
    </item>
  </channel>
</rss>